Acute treatment for bacterial vaginosis has been established for decades and is reliably effective. The clinical problem begins afterward. A large proportion of women experience a recurrence within a few months, and to date, there is no treatment for the chronically recurrent form that reliably prevents relapse. A randomized study published in 2025 addresses this gap by offering a new answer to an old question: Will a woman recover if her partner is also treated?
Autoren
- Jens Dehn
Publikation
- GYNÄKOLOGIE PRAXIS
Related Topics
You May Also Like
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Statement
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations